Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $149.5900 (0.59%) ($147.1500 - $149.7100) on Fri. Jan. 20, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.19% (three month average) | RSI | 28 | Latest Price | $149.5900(0.59%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.3% a day on average for past five trading days. | Weekly Trend | ABBV declines -3.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) IBB(20%) XLV(20%) SPLV(17%) XLP(16%) XOP(16%) | Factors Impacting ABBV price | ABBV will decline at least -0.595% in a week (0% probabilities). XLC(-14%) IPO(-12%) BWX(-10%) BNDX(-9%) IGOV(-8%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.595% (StdDev 1.19%) | Hourly BBV | -0.3 () | Intraday Trend | 0.1% | | | |
|
Resistance Level | $158.6 | 5 Day Moving Average | $150.79(-0.8%) | 10 Day Moving Average | $154.78(-3.35%) | 20 Day Moving Average | $158.6(-5.68%) | To recent high | -10.2% | To recent low | 4.7% | Market Cap | $263.919b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |